Canadian DIN & Molecule SearchMolecules A–ZDrug ShortagesResourcesHealth Canada WeeklyRequest a Quote

ETHACRYNATE SODIUM FOR INJECTION USP DIN 02469456

Status: Dormant
Holder: STERIMAX INC
Molecule: ETHACRYNIC ACID (ETHACRYNATE SODIUM)
Available to quote

Health Canada record

Active ingredient(s)ETHACRYNIC ACID (ETHACRYNATE SODIUM) 50 MG
Dosage formPowder For Solution
RouteIntravenous
SchedulePRESCRIPTION
ClassHuman
ATCC03CC01 ETACRYNIC ACID
Original market date29-Mar-2018
Current status date27-Jun-2024
SourceHealth Canada DPD

Establishment licence of the holder

Sterimax Inc — licence 100925, currently licensed, last inspection rating C (2024-05-13).

No Canadian shortage report is currently matched to this DIN.

Other Canadian products containing ETHACRYNIC ACID (ETHACRYNATE SODIUM)

DINProductCompanyFormStrengthStatus
02462362ETHACRYNATE SODIUMSTERIMAX INCPowder For SolutionETHACRYNIC ACID (ETHACRYNATE SODIUM) 50 MGMarketed
02479591ETHACRYNATE SODIUM FOR INJECTIONENDO PAR INNOVATION COMPANY, LLCPowder For SolutionETHACRYNIC ACID (ETHACRYNATE SODIUM) 50 MGCancelled Pre Market
00268313SODIUM EDECRINBAUSCH HEALTH, CANADA INC.Powder For SolutionETHACRYNIC ACID (ETHACRYNATE SODIUM) 50 MGDormant

Notices of Compliance

NOCDateSubmissionReason
199932017-11-02Abbreviated New Drug Submission (ANDS)
Request a quote for ETHACRYNATE SODIUM FOR INJECTION USP

How to read a Canadian DIN record